Skip to main content
Premium Trial:

Request an Annual Quote

Leigh Anderson

Premium
Leigh Anderson has been appointed to the scientific advisory board of biOasis Technologies, the company said this week.
 
Anderson is the founder and CEO of the Plasma Proteome Institute, and was chief scientific officer at Large Scale Biology, where he founded the proteomics division in 1985. LSB merged with Biosource Technologies in 1999.
 
biOasis, based in British Columbia, develops and commercializes diagnostics and therapeutics for neurological diseases.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.